LIVE

/Plasma Freeze/Cofagrigus

Variants

MARGINAL · Conviction 4/10

Cofagrigus

Plasma Freeze · #57 · Rare

Live NM ask

€1.50

↓ 15.0% 30D

PSA 9

€15.57

USD source

PSA 10

€43.12

USD source

Composite

4.2

Confidence 4/10

4.2

Verify externally — possibly stale

View listing →View price reference →

Buy range€0.98 – €1.28At market

All prices and projections are for Near Mint English-language cards. Other conditions and languages may vary significantly.

Price history

Ungraded NM PSA 9 PSA 10

Investment thesis

Sub-score breakdown · ROI projections

4.2

SCORE / 10

Liquidity

8.9

Scarcity

—

Era potential

3.3

Friction

6.1

Hold-Raw · 5Y Outlook▲ PRIMARY

+•••%

Available with Pro

Grade or sell · per-card

Free account

See if grading this card pays.

How is this scored?

The composite score (0–10) blends signals across trust, set tier, era, liquidity, and price. The four sub-scores shown above (Liquidity, Scarcity, Era CAGR, Friction) describe each card across complementary axes; they share inputs with the composite but use different formulas. The Friction sub-score (added 2026-05-11) combines liquidity, price-spread stability, era maturity, and affordability minus a flat marketplace-fee proxy. The era-benchmark ROI numbers project returns based on the card's release era — they're not card-specific predictions. Limitations: the score is a relative ranking heuristic, not a forecast. Prices are snapshots and can drift between refreshes — always verify externally before buying.

Pop report

PSA 10 gem rate 0.00%Total population

PSA 10

PSA 9

PSA 8

Total graded

Gem rate 0.00%. A notably low ratio implying friction in the grading pipeline — supportive of the gem-rate compression thesis.

OVERVIEW

Investment summary

The Plasma Freeze Cofagrigus (#57) currently trades at €4.49 in the raw market. Its 30-day price movement has declined (-15.0%). By market value it ranks #48 of 122 in Plasma Freeze — the 60th percentile of the set. With recent sales tracked over the trailing 180 days, liquidity is rated low. Read together, a mid-tier ranking in Plasma Freeze alongside softening 30-day momentum frames where Cofagrigus sits in the set's pricing structure — context worth weighing against the set's stronger names before timing an entry. Market data is informational only and does not constitute investment advice.